CII-CPPIntegrative Interventions for Chronic Pelvic Pain
My Pelvic Plan
+ Bend
Neurologic Manifestations+2
+ Pain
+ Signs and Symptoms
Treatment Study
Summary
Study start date: August 12, 2025
Actual date on which the first participant was enrolled.This study focuses on testing different integrative treatment methods for individuals who experience chronic pelvic pain. Chronic pelvic pain is a condition that affects many people, often leading to discomfort and affecting daily life. The aim is to find effective ways to alleviate this pain using various approaches. This is significant because current treatments might not work for everyone, and finding new strategies could greatly improve the quality of life for those affected. Participants in this study will undergo different treatment methods to see which provides the best relief from pelvic pain. The study will use "My Pelvic Plan," recognized as a medical device under FDA enforcement discretion. Although specific procedures and measurements are not detailed, the study will likely assess changes in pain levels and overall wellbeing. By comparing the outcomes of these interventions, researchers hope to identify the most effective options for managing chronic pelvic pain.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.49 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 18 to 55 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location